Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 11 studies | 30% ± 10% | |
| ciliated cell | 6 studies | 24% ± 7% | |
| oligodendrocyte precursor cell | 6 studies | 30% ± 13% | |
| GABAergic neuron | 5 studies | 35% ± 16% | |
| astrocyte | 5 studies | 23% ± 8% | |
| neuron | 4 studies | 24% ± 9% | |
| glutamatergic neuron | 4 studies | 45% ± 14% | |
| interneuron | 4 studies | 36% ± 21% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 37% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1566.97 | 2641 / 2642 | 100% | 12.20 | 704 / 705 |
| esophagus | 100% | 711.63 | 1442 / 1445 | 98% | 9.50 | 180 / 183 |
| breast | 100% | 687.13 | 458 / 459 | 98% | 8.57 | 1093 / 1118 |
| lung | 99% | 710.87 | 573 / 578 | 96% | 6.40 | 1107 / 1155 |
| uterus | 100% | 1090.01 | 170 / 170 | 95% | 6.97 | 435 / 459 |
| thymus | 100% | 769.07 | 653 / 653 | 93% | 4.53 | 562 / 605 |
| skin | 100% | 835.30 | 1802 / 1809 | 89% | 7.53 | 422 / 472 |
| adrenal gland | 99% | 723.12 | 256 / 258 | 90% | 5.03 | 206 / 230 |
| prostate | 99% | 664.02 | 243 / 245 | 86% | 3.89 | 434 / 502 |
| bladder | 100% | 720.67 | 21 / 21 | 86% | 4.74 | 431 / 504 |
| ovary | 100% | 927.46 | 180 / 180 | 85% | 4.09 | 366 / 430 |
| stomach | 96% | 511.61 | 346 / 359 | 87% | 4.04 | 248 / 286 |
| kidney | 98% | 442.70 | 87 / 89 | 83% | 3.81 | 750 / 901 |
| intestine | 100% | 806.30 | 964 / 966 | 80% | 3.27 | 421 / 527 |
| pancreas | 79% | 239.94 | 258 / 328 | 85% | 3.62 | 151 / 178 |
| spleen | 100% | 864.43 | 241 / 241 | 0% | 0 | 0 / 0 |
| liver | 67% | 186.84 | 151 / 226 | 33% | 1.15 | 134 / 406 |
| adipose | 100% | 626.19 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 800.61 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 98% | 631.41 | 790 / 803 | 0% | 0 | 0 / 0 |
| heart | 93% | 438.10 | 798 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 9.23 | 41 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 5.97 | 26 / 29 |
| peripheral blood | 64% | 530.89 | 591 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 24% | 0.65 | 19 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1901673 | Biological process | regulation of mitotic spindle assembly |
| GO_1902018 | Biological process | negative regulation of cilium assembly |
| GO_0030030 | Biological process | cell projection organization |
| GO_0005814 | Cellular component | centriole |
| GO_0005813 | Cellular component | centrosome |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0005516 | Molecular function | calmodulin binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CEP97 |
| Protein name | Centrosomal protein of 97 kDa (Cep97) (Leucine-rich repeat and IQ domain-containing protein 2) Centrosomal protein 97 |
| Synonyms | LRRIQ2 |
| Description | FUNCTION: Acts as a key negative regulator of ciliogenesis in collaboration with CCP110 by capping the mother centriole thereby preventing cilia formation . Required for recruitment of CCP110 to the centrosome . . |
| Accessions | E9PG22 ENST00000341893.8 [Q8IW35-1] A0A994J4L0 A0A994J715 A0A994J7E5 ENST00000467655.2 ENST00000704367.1 F8WF91 H7C4Y5 A0A994J4D7 ENST00000704446.1 A0A994J522 A0A994J704 A0A994J4M7 Q8IW35 ENST00000465011.2 ENST00000704369.1 ENST00000704366.1 ENST00000704365.1 [Q8IW35-2] ENST00000704444.1 ENST00000494050.5 ENST00000704445.1 ENST00000704370.1 |
